Market Value11,019,928,000
Total Holdings134
File Date2016-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
MGNX / MacroGenics, Inc.
BCRX / BioCryst Pharmaceuticals, Inc.
WINT / Windtree Therapeutics, Inc.
NLTX / Neoleukin Therapeutics, Inc.
ABEO / Abeona Therapeutics Inc.
ADMS / Adamas Pharmaceuticals Inc
XNCR / Xencor, Inc.
FOMX / Foamix Pharmaceuticals Ltd.
CYCCP / Cyclacel Pharmaceuticals, Inc. - Preferred Stock
INCY / Incyte Corporation
MDGL / Madrigal Pharmaceuticals, Inc.
CNCE / Concert Pharmaceuticals Inc
ABBV / AbbVie Inc.
CMRX / Chimerix, Inc.
PTN / Palatin Technologies, Inc.
PGNX / Progenics Pharmaceuticals, Inc.
GNMX / Aevi Genomic Medicine, Inc.
74365AAB7 / Protalix BioTherapeutics, Inc. Bonds 4.5% 9/15/18
US00767EAB83 / Aegerion Pharmaceuticals, Inc. 2.0% Bond due 2019-08-15
ECYT / Endocyte, Inc.
45337CAK8 / Incyte Corporation Bonds 0.375% 11/15/2018
09061GAD3 / BioMarin Pharmaceutical Inc. Bond 1.875% 4/23/2017
US189464AB64 / Clovis Oncology, Inc. 2.5% 9/15/2021
ARCT / Arcturus Therapeutics Holdings Inc.
BTX.WS / BioTime, Inc. Warrants exp. 2018-10-01
CLCD / CoLucid Pharmaceuticals, Inc.
45780VAB8 / Inotek Pharmaceuticals Corporation Bonds 5.75% 8/1/2021
XNPT / XenoPort, Inc.
APTO / Aptose Biosciences Inc.
ALDR / Alder BioPharmaceuticals, Inc.
ZGNX / Zogenix Inc
VTAE / Vitae Pharmaceuticals, Inc.
PRQR / ProQR Therapeutics N.V.
FMI / Foundation Medicine, Inc.
NDRM / NeuroDerm Ltd.
MDWD / MediWound Ltd.
IMDZ / Immune Design Corp.
451731103 / Ignyta, Inc.
SVRA / Savara Inc.
LGND / Ligand Pharmaceuticals Incorporated
OSIR / Osiris Therapeutics, Inc.
04269XAA3 / Array BioPharma Inc. Bonds 3.0% 6/1/2020
US62857M1053 / MyoKardia, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
GHDX / Genomic Health, Inc.
DMTX / Dimension Therapeutics, Inc.
AAAP / Advanced Accelerator Applications S.A
/ Array BioPharma, Inc.
STML / Stemline Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
ONCE / Spark Therapeutics, Inc.
CERS / Cerus Corporation
DSCI / Derma Sciences, Inc.
AERI / Aerie Pharmaceuticals Inc
SCYX / SCYNEXIS, Inc.
MDVN / Medivation, Inc.
TGTX / TG Therapeutics, Inc.
CYTR / LadRx Corp
AUPH / Aurinia Pharmaceuticals Inc.
ALNY / Alnylam Pharmaceuticals, Inc.
GWP / GW Pharmaceuticals plc
ABUS / Arbutus Biopharma Corporation
NVIV / InVivo Therapeutics Holdings Corp.
KPTI / Karyopharm Therapeutics Inc.
NBRV / Nabriva Therapeutics Plc
CLLS / Cellectis S.A. - Depositary Receipt (Common Stock)
XLRN / Acceleron Pharma Inc
US33830X1046 / Five Prime Therapeutics Inc
US0153511094 / Alexion Pharmaceuticals, Inc.
SAGE / Sage Therapeutics, Inc.
EPZM / Epizyme Inc
SELB / Selecta Biosciences Inc
JUNO / Juno Therapeutics, Inc.
0HBB / Aimmune Therapeutics Inc
09061GAE1 / BioMarin Pharmaceutical Inc. Bond 0.75% 10/15/2018
DERM / Journey Medical Corporation
INSM / Insmed Incorporated
NTLA / Intellia Therapeutics, Inc.
ARWR / Arrowhead Pharmaceuticals, Inc.
45337CAL6 / Incyte Corporation Bonds 1.25% 11/15/2020
TARA / Protara Therapeutics, Inc.
IONS / Ionis Pharmaceuticals, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)
IDRA / Idera Pharmaceuticals, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
IMGN / ImmunoGen, Inc.
TRIL / Trillium Therapeutics Inc
SGMO / Sangamo Therapeutics, Inc.
HALO / Halozyme Therapeutics, Inc.
BDSI / Biodelivery Sciences International
TRVN / Trevena, Inc.
MCRB / Seres Therapeutics, Inc.
/ Achaogen Inc
ITCI / Intra-Cellular Therapies, Inc.
AGIO / Agios Pharmaceuticals, Inc.
MRUS / Merus N.V.
EXEL / Exelixis, Inc.
INFI / Infinity Pharmaceuticals Inc.
VIRX / Viracta Therapeutics, Inc.
NERV / Minerva Neurosciences, Inc.
CFRX / ContraFect Corp
ALKS / Alkermes plc
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
QURE / uniQure N.V.
LOXO / Loxo Oncology, Inc.
ASMB / Assembly Biosciences, Inc.
US00484MAA45 / Acorda Therapeutics, Inc. Bond 1.750% 6/1
AKTX / Akari Therapeutics, Plc - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
GLYC / GlycoMimetics, Inc.
SYRS / Syros Pharmaceuticals, Inc.
RARE / Ultragenyx Pharmaceutical Inc.
BLUE / bluebird bio, Inc.
FLGT / Fulgent Genetics, Inc.
NVAX / Novavax, Inc.
ALDX / Aldeyra Therapeutics, Inc.
HRTX / Heron Therapeutics, Inc.
LJPC / La Jolla Pharmaceutical Co.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
QLGN / Qualigen Therapeutics, Inc.
CPRX / Catalyst Pharmaceuticals, Inc.
SRRA / Sierra Oncology Inc
ACOR / Acorda Therapeutics, Inc.
CRIS / Curis, Inc.
CCXI / ChemoCentryx Inc
TENX / Tenax Therapeutics, Inc.
ENTA / Enanta Pharmaceuticals, Inc.
AFMD / Affimed N.V.
NBIX / Neurocrine Biosciences, Inc.
DVAX / Dynavax Technologies Corporation
AMRN / Amarin Corporation plc - Depositary Receipt (Common Stock)
NTRA / Natera, Inc.
AGLE / Aeglea BioTherapeutics Inc
BLCM / Bellicum Pharmaceuticals, Inc.
SGEN / Seagen Inc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ARAV / Aravive, Inc.
NVTA / Invitae Corporation
MRTX / Mirati Therapeutics, Inc.